Vycor Medical, Inc.
VYCO
$0.175
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 339.00% | -26.14% | 92.80% | -15.22% | -114.62% |
| Total Depreciation and Amortization | -4.46% | 3.21% | 11.92% | 3.29% | 3.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | 152.05% | 736.36% | 67.86% | -100.00% |
| Change in Net Operating Assets | -113.45% | -340.00% | -182.27% | 162.63% | 210.76% |
| Cash from Operations | -45.81% | -1,515.79% | -796.36% | 170.47% | 505.63% |
| Capital Expenditure | -- | -- | 103.39% | -25.71% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -40.00% | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 103.39% | -25.00% | -100.00% |
| Total Debt Issued | -- | -- | 100.00% | -3.33% | -- |
| Total Debt Repaid | 50.94% | -10.63% | -43.30% | 1.75% | -0.95% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 50.94% | -10.63% | -21.93% | -4.64% | -20.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -48.67% | -232.84% | -340.68% | 143.95% | 1,246.43% |